A comparative study to evaluate efficacy, safety and cost effectiveness between to evaluate efficacy, safety and topical 1% Butenafine vs topical 2% Sertaconazole in tinea infections of skin

Trial Profile

A comparative study to evaluate efficacy, safety and cost effectiveness between to evaluate efficacy, safety and topical 1% Butenafine vs topical 2% Sertaconazole in tinea infections of skin

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Butenafine (Primary) ; Sertaconazole (Primary)
  • Indications Tinea
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top